{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:51:57Z","timestamp":1790859117744,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.antiviral.2020.104974","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:29:50Z","timestamp":1605616190000},"page":"104974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2"],"prefix":"10.1016","volume":"185","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104974_bib1","article-title":"Compassionate use of remdesivir in covid-19","volume":"382","author":"Bonovas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104974_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/22221751.2020.1725399","article-title":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2020.104974_bib3","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1099\/jgv.0.000607","article-title":"Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5","volume":"97","author":"Du","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104974_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104974_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104974_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virol.2006.10.016","article-title":"Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening","volume":"360","author":"Ge","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104974_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"Kohli","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.antiviral.2020.104974_bib8","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.2147\/DDDT.S259058","article-title":"Antiviral agent therapy optimization in special populations of COVID-19 patients","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.antiviral.2020.104974_bib9","unstructured":"Masters, P.S., Perlman, S., sixth ed.. Coronaviridae. Fields Virology, 825-858."},{"key":"10.1016\/j.antiviral.2020.104974_bib10","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1128\/AAC.00498-08","article-title":"Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance","volume":"52","author":"Mathy","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104974_bib11","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I","volume":"79","author":"Stumper","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104974_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature24039","article-title":"CG dinucleotide suppression enables antiviral defence targeting non-self RNA","volume":"550","author":"Takata","year":"2017","journal-title":"Nature"},{"issue":"7813","key":"10.1016\/j.antiviral.2020.104974_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","article-title":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform","volume":"582","author":"Thao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104974_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104974_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104974_bib16","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/S2665-9913(20)30093-X","article-title":"Caution and clarity required in the use of chloroquine for COVID-19","volume":"2","author":"Wong","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.antiviral.2020.104974_bib17","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/molbev\/msaa094","article-title":"Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense","volume":"37","author":"Xia","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2020.104974_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An infectious cDNA clone of SARS-CoV-2","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2020.104974_bib19","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1128\/JVI.01634-06","article-title":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist","volume":"81","author":"Ye","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104974_bib20","series-title":"Multi-site Co-mutations and 5\u2019UTR CpG Immunity Escape Drive the Evolution of SARS-CoV-2","author":"Zhang","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104974_bib21","first-page":"15","article-title":"Isolation of a 2019 novel coronavirus strain from a coronavirus disease 19 patient in Shanghai","volume":"15","author":"Zhang","year":"2020","journal-title":"Journal of Microbes and Infection"},{"key":"10.1016\/j.antiviral.2020.104974_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104974_bib23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104974_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:08Z","timestamp":1759062728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"alternative-id":["S0166354220303880"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104974","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.11.294330","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104974"}}